glp-1 microdosing research medications are changing how people think about weight loss, diabetes care and even cravings. Now, more people are talking about “microdosing” GLP-1s. That usually means taking less than the typical prescribed Microdosing GLP-1s: Risks & Considerations

Initial clinical trials with kisspeptin demonstrate potential to enhance implantation and pregnancy rates, while kisspeptin measurement can assist in evaluating reproductive health

Currently, the BPC-157 peptide is not FDA-approved, and research is ongoing regarding its medical applications

Similar trials are assessing GLP-1RAs in overweight patients with IBD (110), in UC (NCT06937086), and exploring dual GLP-1/GIP agonists like Zepbound as adjunctive therapies (NCT06774079) (112)

2021;10: e016835

At Boca Medical Care, we are committed to supporting your journey toward optimal health and fitness through our health education programs

The scale does not tell the whole story